This commentary highlights the research presented by Li et al. [15]. In this issue of Clinical Science, which demonstrates that dual specific phosphatase 12 (DUSP12), through JNK1/2 inhibition, alleviates cardiac hypertrophy in response to pressure overload, making it a potential therapeutic target.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society
2016
You do not currently have access to this content.
